Trillium Therapeutics' IPO

Trillium Therapeutics raised a round of funding on April 02, 2015. Investors include Public.

Trillium Therapeutics is a research and development company developing therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses, includin…

Articles about Trillium Therapeutics' IPO: